(12) United States Patent (10) Patent No.: US 8,840,869 B2 Friedman Et Al

(12) United States Patent (10) Patent No.: US 8,840,869 B2 Friedman Et Al

USOO8840869B2 (12) United States Patent (10) Patent No.: US 8,840,869 B2 Friedman et al. (45) Date of Patent: Sep. 23, 2014 (54) BODY CAVITY FOAMS (56) References Cited (75) Inventors: Doron Friedman, Karmei Yosef (IL); U.S. PATENT DOCUMENTS Alex Besonov, Rehovet (IL); Dov 1,159,250 A 11/1915 Moulton Tamarkin, Maccabim (IL); Meir Eini, 1,666,684 A 4, 1928 Carstens Ness Ziona (IL) 1924,972 A 8, 1933 Beckert 2,085,733. A T. 1937 Bird (73) Assignee: Foamix Ltd., Rehovot (IL) 2,390,921 A 12, 1945 Clark 2,524,590 A 10, 1950 Boe 2,586.287 A 2/1952 Apperson (*) Notice: Subject to any disclaimer, the term of this 2,617,754 A 1 1/1952 Neely patent is extended or adjusted under 35 2,767,712 A 10, 1956 Waterman U.S.C. 154(b) by 1533 days. 2.968,628 A 1/1961 Reed 3,004,894 A 10/1961 Johnson et al. (21) Appl. No.: 11/116,761 3,062,715 A 11/1962 Reese 3,067,784. A 12/1962 Gorman 3,092.255. A 6, 1963 Hohman (22) Filed: Apr. 28, 2005 3,092,555 A 6, 1963 Horn 3,141,821 A 7, 1964 Compeau (65) Prior Publication Data 3,142,420 A 7/1964 Gawthrop 3,144,386 A 8/1964 Brighttenback US 2005/0271598 A1 Dec. 8, 2005 3,149,543 A 9, 1964 Naab 3,154,075 A * 10/1964 Weckesser .................... 604/279 3,178,352 A 4, 1965 Erickson Related U.S. Application Data 3,236,457 A 2, 1966 Kennedy et al. 3,244,589 A 4, 1966 Sunnen (63) Continuation-in-part of application No. 10/532,618, 3,252,859 A 5, 1966 Silver filed as application No. PCT/IB03/05527 on Oct. 24, 3,261,695 A 7, 1966 Sienciewicz 2003, application No. 1 1/116,761, which is a 3,263,867 A 8, 1966 Lehmann continuation-in-part of application No. 10/911,367, 3,263,869 A 8, 1966 Corsette filed on Aug. 4, 2004. 3,298.919 A 1/1967 Bishop et al. (60) Provisional application No. 60/429,546, filed on Nov. (Continued) 29, 2002, provisional application No. 60/556,513, FOREIGN PATENT DOCUMENTS filed on Mar. 25, 2004. AU 19878O257 9, 1986 (30) Foreign Application Priority Data AU 7825.15 12/2005 (Continued) Oct. 25, 2002 (IL) .......................................... 1524.86 OTHER PUBLICATIONS Nicol. AIDS 2001, vol. 15 No. 14 pp. 1837-1842.* (51) Int. C. Pendergrass. Gynecol Obstet Invest. 1996:42(3):178-82.* A6 IK 8/00 (2006.01) Kinnunen. Contact Dermatitis. Sep. 1989:21(3): 154-8.* A61O 19/04 (2006.01) International Search Report from PCT/IB2005/004164, mailed Oct. A6 IK 9/12 23, 2006, 7 pages. (2006.01) Barry, B.W. et al. Comparative bio-availability and activity of pro A61O 700 (2006.01) prietary topical corticosteroid preparations: vasoconstrictor assays A61O 19/02 (2006.01) on thirty-one ointments, British Journal of Dermatology, 93, 563 A6 IK 8/60 (2006.01) 571, 1975. A61O 1702 (2006.01) Tamarkin, D., et al. Moisturizing Foam Containing Lanolin, U.S. A6 IK9/00 (2006.01) Appl. No. 1 1/099.942, filed Apr. 6, 2005. A61O 1704 (2006.01) Tamarkin, D., et al. Nonsteroidal Immunomodulating Kit and Com A6 IK9/46 position and Uses Thereof, U.S. Appl. No. 11/078.902, filed Mar. 11, (2006.01) 2005. A6 IK 8/04 (2006.01) Tamarkin, D., etal. Steroid Kit and Foamable Composition and Uses, A61O 702 (2006.01) U.S. Appl. No. 1 1/114,410, filed Apr. 26, 2005. (52) U.S. C. CPC .............. A61K 9/0007 (2013.01); A61O 19/04 (Continued) (2013.01); A61K 9/12 (2013.01); A61O 700 Primary Examiner — Suzanne Ziska (2013.01); A61O 19/02 (2013.01); A61K 8/60 (74) Attorney, Agent, or Firm — Fish & Richardson P.C. (2013.01); A61 K9/122 (2013.01); A61O 1702 (2013.01); A61 K9/0014 (2013.01); A61O (57) ABSTRACT 1704 (2013.01); A61 K 2800/75 (2013.01); The invention relates to an alcohol-free cosmetic ortherapeu A61K 8/046 (2013.01); A61 K9/0034 tic foam carrier comprising water, a hydrophobic organic (2013.01); A61O 702 (2013.01) carrier, a foam adjuvant agent, a Surface-active agent and a USPC ............................................................ 424/47 gelling agent. The cosmetic or therapeutic foam carrier does (58) Field of Classification Search not contain aliphatic alcohols, making it non-irritating and CPC ... A61K 8/046; A61 K9/0014: A61 K9/0034; non-drying. The alcohol-free foam carrier is suitable for A61 K9/12: A61 K9/122 inclusion of both water-soluble and oil soluble therapeutic USPC ............................................................ 424/47 and cosmetic agents. See application file for complete search history. 38 Claims, No Drawings US 8,840,869 B2 Page 2 (56) References Cited 4,305,936 A 12/1981 Klein 4,309,995 A 1/1982 Sacco U.S. PATENT DOCUMENTS 4,310,510 A * 1/1982 Sherman et al. ................ 424/45 4.323,582 A 4/1982 Siegel et al. 3,301,444 A 1, 1967 Wittke 4.323,694. A 4, 1982 Scala, Jr. 3,303,970 A 2f1967 Breslau et al. 4.325,939 A 4, 1982 Shah 3,330,730 A 7, 1967 Hernandez 4.329,990 A 5/1982 Sneider 3,333,333 A 8, 1967 Noack 4,335,120 A 6, 1982 Holicket al. 3,334,147 A 8, 1967 Brunelle et al. 4,352,808 A 10, 1982 Rane et al. 3,346,451 A 10/1967 Collins et al. 4.385,161 A 5/1983 Caunt et al. 3,366,494. A 1, 1968 Bower et al. 4,386,104 A 5/1983 Nazzaro-Porro 3,369,034 A 2f1968 Chalmers 4,393,066 A 7/1983 Garrett et al. 3,377,004 A 4, 1968 Wittke 4.427,670 A 1/1984 Ofuchi et al. 3,384.541 A 5, 1968 Clarket al. 4,439,416 A 3, 1984 Cordon et al. 3,395.214 A 7, 1968 Mummert 4,439,441 A 3/1984 Hallesy et al. 3.395.25 A 7, 1968 Schubert 4,440,320 A 4, 1984 Wernicke 3,401,849 A 9/1968 Weber, III 4,447.486 A 5/1984 Hoppe et al. 3.419,658 A 12/1968 Sanders 4,469,674. A 9, 1984 Shah et al. 3.456,052 A 7, 1969 Gordon 4,508,705 A 4, 1985 Chaudhuri et al. 3,527,559 A 9, 1970 Sliwinski 4,522,948 A 6, 1985 Walker 3,540,448 A 11, 1970 Sunnen 4,529,601 A 7/1985 Broberg et al. 3,559,890 A 2f1971 Brooks et al. 4,529,605 A 7/1985 Lynch et al. 3,561,262 A 2f1971 Borucki 4,552,872 A 1 1/1985 Cooper et al. 3,563,098 A 2/1971 Weber, III 4,574,052 A 3/1986 Gupte et al. 3,574,821 A 4, 1971 Pfirrmann 4,576,961 A 3, 1986 Lorck et al. 3,577,518 A 5/1971 Shepherd 4,595,526 A 6, 1986 Lai 3.667.461 A 6, 1972 Zamarra 4,603,812 A 8, 1986 Stoesser et al. 3.751562 A 8, 1973 Nichols 4,627,973 A 12/1986 Moran et al. 3,770,648 A 11, 1973 Mackles 4,628,063 A 12/1986 Haines et al. 3,787,566 A 1/1974 Gauvreau 4,661.524. A 4, 1987 Thomson et al. 3,819,524 A 6, 1974 Schubert et al. 4,672,078 A 6, 1987 Sakai et al. 3,841,525 A 10/1974 Siegel 4,673,569 A 6, 1987 Shernov et al. 3,849,580 A 1 1/1974 Weinstein et al. 4,678,463 A 7, 1987 Millar 3.865.275 A 2f1975 De Nunzio 4,701,320 A 10/1987 Hasegawa et al. 3.866,800 A 2, 1975 Schmitt 4,725,609 A 2/1988 Kull, Jr. et al. 3,882,228 A 5/1975 Boncey et al. 4,738,396 A 4, 1988 Doi et al. 3,886,084 A 5, 1975 Vassiliades 4,741,855 A 5, 1988 Grote et al. 3,890,305 A 6, 1975 Weber et al. 4,752.465 A 6, 1988 Mackles 3,912,665 A 10/1975 Spitzer et al. 4,770,634 A 9, 1988 Pelico 3,923,970 A 12/1975 Breuer 4,772,427 A 9, 1988 Dawson 3,929,985 A * 12/1975 Webb, Jr. ........................ 424/45 4,780,309 A 10/1988 Geria et al. 3,952,916 A 4/1976 Phillips 4,784.842 A 11/1988 London et al. 3,959,160 A 5, 1976 Horsler et al. 4,792,062. A 12/1988 Goncalves 3,962,150 A 6, 1976 Viola 4,798,682 A 1, 1989 Ansmann 3,963,833. A 6, 1976 DeSalva et al. 4,804.674. A * 2/1989 Curtis-Prior et al. ......... 514,400 3,966,090 A 6, 1976 Prussin et al. 4,806,262 A 2/1989 Snyder 3,966,632 A 6/1976 Colliopoulos et al. 4,808,388 A 2f1989 Beutler et al. 3,970,219 A 7/1976 Spitzer et al. 4,822,613 A 4, 1989 Rodero 3,970,584 A 7, 1976 Hart et al. 4,822,614 A 4, 1989 Rodero 3,993,224 A 11, 1976 Harrison 4,826,048 A 5/1989 Skorka et al. 3,997.467 A 12/1976 Jederstrom 4,827,378 A 5/1989 Gillan et al.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    32 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us